179 results on '"Marchena P."'
Search Results
2. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia
- Author
-
Cohen, Omri, Waldman Radinsky, Liat, Kenet, Gili, Mahé, Isabelle, Barillari, Giovanni, Soler, Silvia, Sigüenza, Patricia, Del Valle Morales, María, Villares, Paula, Monreal, Manuel, Adarraga, MD, Alberich-Conesa, A, Aibar, J, Alda-Lozano, A, Alfonso, J, Amado, C, Angelina-García, M, Arcelus, JI, Ballaz, A, Barba, R, Barbagelata, C, Barrón, M, Barrón-Andrés, B, Beddar-Chaib, F, Blanco-Molina, A, Caballero, JC, Castellanos, G, Criado, J, De Ancos, C, Del Toro, J, Demelo-Rodríguez, P, De Juana-Izquierdo, C, Díaz-Peromingo, JA, Dubois-Silva, A, Escribano, JC, Falgá, C, Farfán-Sedano, AI, Fernández-Aracil, C, Fernández-Capitán, C, Fernández-Jiménez, B, Fernández-Reyes, JL, Fidalgo, MA, Francisco, I, Gabara, C, Galeano-Valle, F, García-Bragado, F, García-Ortega, A, Gavín-Sebastián, O, Gil-Díaz, A, Gómez-Cuervo, C, González-García, C, González-Munera, A, Grau, E, Guirado, L, Gutiérrez-Guisado, J, Hernández-Blasco, L, Herreros, M, Jara-Palomares, L, Jaras, MJ, Jiménez, D, Jou, I, Joya, MD, Lecumberri, R, Llamas, P, Lobo, JL, López-Jiménez, L, López-Miguel, P, López-Brull, H, López-Núñez, JJ, López-Ruiz, A, López-Sáez, JB, Lorenzo, A, Lumbierres, M, Madridano, O, Maestre, A, Marchena, PJ, Marcos, M, Martín del Pozo, M, Martín-Martos, F, Martínez-Prado, R, Maza, JM, Mena, E, Mercado, MI, Moisés, J, Molino, A, Monreal, M, Morales, MV, Navas, MS, Nieto, JA, Núñez-Fernández, MJ, Olid, M, Ordieres-Ortega, L, Ortiz, M, Osorio, J, Otálora, S, Otero, R, Pacheco-Gómez, N, Pagán, J, Palomeque, AC, Paredes, E, Parra-Caballero, P, Pedrajas, JM, Pérez-Ductor, C, Pérez-Pinar, M, Peris, ML, Pesce, ML, Porras, JA, Puchades, R, Rivera-Cívico, F, Rodríguez-Cobo, A, Romero-Brugera, M, Ruiz-Artacho, P, Ruiz-Giménez, N, Ruiz-Ruiz, J, Salgueiro, G, Sancho, T, Sendín, V, Sigüenza, P, Soler, S, Steinherr, A, Suárez-Fernández, S, Tirado, R, Torrents-Vilar, A, Torres, MI, Trujillo-Santos, J, Uresandi, F, Valle, R, Varona, JF, Villalobos, A, Villares, P, Ay, C, Nopp, S, Pabinger, I, Vanassche, T, Verhamme, P, Verstraete, A, Yoo, HHB, Montenegro, AC, Morales, SN, Roa, J, Hirmerova, J, Malý, R, Bertoletti, L, Bura-Riviere, A, Catella, J, Chopard, R, Couturaud, F, Espitia, O, Grange, C, Le Mao, R, Leclercq, B, Mahé, I, Morange, P, Moustafa, F, Plaisance, L, Sarlon-Bartoli, G, Suchon, P, Versini, E, Schellong, S, Brenner, B, Dally, N, Kenet, G, Tzoran, I, Sadeghipour, P, Rashidi, F, Abenante, A, Barillari, G, Basaglia, M, Bertoni, M, Bilora, F, Brandolin, B, Ciammaichella, M, Colaizzo, D, Dentali, F, Di Micco, P, Grandone, E, Imbalzano, E, Negro, F, Pesavento, R, Poz, A, Prandoni, P, Siniscalchi, C, Taflaj, B, Tufano, A, Visonà, A, Zalunardo, B, Skride, A, Kigitovica, D, Zicans, M, Fonseca, S, Marques, R, Meireles, J, Pinto, S, Bosevski, M, Trajkova, M, Zdraveska, M, Bounameaux, H, Mazzolai, L, Aujayeb, A, Caprini, JA, Weinberg, I, and Bui, HM
- Abstract
•In a RIETE registry analysis of 103 818 patients with VTE, 20.3% were tested for IT, showing a substantial variance in outcomes.•A thoughtful IT testing approach should consider patients’ VTE risk factors and comorbidities.
- Published
- 2024
- Full Text
- View/download PDF
3. BMP-Binding Polysulfonate Brushes to Control Growth Factor Presentation and Regulate Matrix Remodelling
- Author
-
Marchena, Metzli Hernandez, Lambert, Elisa, Bogdanović, Bojana, Quadir, Fauzia, Neri-Cruz, Carlos E., Luo, Jiajun, Nadal, Clemence, Migliorini, Elisa, and Gautrot, Julien E.
- Abstract
Bone morphogenetic proteins (BMPs) are important targets to incorporate in biomaterial scaffolds to orchestrate tissue repair. Glycosaminoglycans (GAGs) such as heparin allow the capture of BMPs and their retention at the surface of biomaterials at safe concentrations. Although heparin has strong affinities for BMP2 and BMP4, two important types of growth factors regulating bone and tissue repair, it remains difficult to embed stably at the surface of a broad range of biomaterials and degrades rapidly in vitro and in vivo. In this report, biomimetic poly(sulfopropyl methacrylate) (PSPMA) brushes are proposed as sulfated GAG mimetic interfaces for the stable capture of BMPs. The growth of PSPMA brushes via a surface-initiated activator regenerated by electron transfer polymerization is investigated via ellipsometry, prior to characterization of swelling and surface chemistry via X-ray photoelectron spectroscopy and Fourier transform infrared. The capacity of PSPMA brushes to bind BMP2 and BMP4 is then characterized via surface plasmon resonance. BMP2 is found to anchor particularly stably and at high density at the surface of PSPMA brushes, and a strong impact of the brush architecture on binding capacity is observed. These results are further confirmed using a quartz crystal microbalance with dissipation monitoring, providing some insights into the mode of adsorption of BMPs at the surface of PSPMA brushes. Primary adsorption of BMP2, with relatively little infiltration, is observed on thick dense brushes, implying that this growth factor should be accessible for further binding of corresponding cell membrane receptors. Finally, to demonstrate the impact of PSPMA brushes for BMP2 capture, dermal fibroblasts were then cultured at the surface of functionalized PSPMA brushes. The presence of BMP2 and the architecture of the brush are found to have a significant impact on matrix deposition at the corresponding interfaces. Therefore, PSPMA brushes emerge as attractive coatings for scaffold engineering and stable capture of BMP2 for regenerative medicine applications.
- Published
- 2024
- Full Text
- View/download PDF
4. 1041 - ESTUDIO RETROSPECTIVO CLÍNICO-EPIDEMIOLÓGICO DE LEISHMANIASIS EN UN HOSPITAL COMARCAL
- Author
-
González, Fátima Fernández, Tojeiro, Sandra Chamorro, Canesco, Anabel Martín-Urda Diez, Romero, José Andrés Marchena, and de la Roca Toda Savall, M.
- Published
- 2024
- Full Text
- View/download PDF
5. El Franquismo se fue de fiesta. Ritos festivos y cultura popular durante la dictadura ed. by Claudio Hernández Burgos y César Rina Simón (review)
- Author
-
Marchena-Domínguez, José
- Published
- 2024
6. Symptom-related screening programme for early detection of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the SYSPPE study
- Author
-
Marin-Romero, Samira, Ballaz-Quincoces, Aitor, Gómez-Cuervo, Covadonga, Marchena-Yglesias, Pablo Javier, Lopez-Miguel, Patricia, Francisco-Albesa, Iria, Pedrajas-Navas, Jose Maria, Lumbierres, Marina, Aibar-Arregui, Miguel Angel, Bosco Lopez-Saez, Juan, Perez-Pinar, Montserrat, Baeza-Martinez, Carlos, Riera-Mestre, Antoni, Peris-Sifre, Marisa, Porras-Ledantes, Jose Antonio, Criado-Garcia, Juan, Elias-Hernandez, Teresa, Otero, Remedios, Barca-Hernando, Maria, Muriel, Alfonso, Klok, Frederikus A, and Jara-Palomares, Luis
- Abstract
BackgroundChronic thromboembolic pulmonary hypertension (CTEPH) is the most severe long-term complication of acute pulmonary embolism (PE). We aimed to evaluate the impact of a symptom screening programme to detect CTEPH in PE survivors.MethodsThis was a multicentre cohort study of patients diagnosed with acute symptomatic PE between January 2017 and December 2018 in 16 centres in Spain. Patients were contacted by phone 2 years after the index PE diagnosis. Those with dyspnoea corresponding to a New York Heart Association (NYHA)/WHO scale≥II, visited the outpatient clinic for echocardiography and further diagnostic tests including right heart catheterisation (RHC). The primary outcome was the new diagnosis of CTEPH confirmed by RHC.ResultsOut of 1077 patients with acute PE, 646 were included in the symptom screening. At 2 years, 21.8% (n=141) reported dyspnoea NYHA/WHO scale≥II. Before symptom screening protocol, five patients were diagnosed with CTEPH following routine care. In patients with NYHA/WHO scale≥II, after symptom screening protocol, the echocardiographic probability of pulmonary hypertension (PH) was low, intermediate and high in 76.6% (n=95), 21.8% (n=27) and 1.6% (n=2), respectively. After performing additional diagnostic test in the latter 2 groups, 12 additional CTEPH cases were confirmed.ConclusionsThe implementation of this simple strategy based on symptom evaluation by phone diagnosed more than doubled the number of CTEPH cases. Dedicated follow-up algorithms for PE survivors help diagnosing CTEPH earlier.Trial registration numberNCT03953560.
- Published
- 2024
- Full Text
- View/download PDF
7. Industrial wastewater treatment technologies for reuse, recycle, and recovery: advantages, disadvantages, and gaps
- Author
-
Mejía-Marchena, Ricardo, Maturana-Córdoba, Aymer, Gómez-Cerón, Diego, Quintero-Monroy, Christian, Arismendy-Montes, Luis, and Cárdenas-Pérez, Carlos
- Abstract
ABSTRACTTo reduce demand and discharge, instead of industrial wastewater being not enough treated and disposed of, it can be recycled, reused, or recovered considering well management. Thus, having a substantial decrease in the water need and environmental impacts. The challenge is to select the proper combination of processes based on the wastewater quality and budget limitations. Therefore, we aimed to provide a distinctive and comprehensive perspective on the current state of industrial wastewater treatment technologies by giving a complete overview of their major advantages, disadvantages, and upcoming challenges in the context of the circular economy. This study considered 198 peer-reviewed scientific publications from the Scopus and Google Scholar databases, mostly from the last 5 years. For this, specific search terms and Boolean Operators were applied as inclusion and exclusion criteria. Up to 57 different technologies, from conventional to advanced, were reviewed for reliable and sustainable industrial wastewater treatment and derived sludges. We evidence a vast potential to exploit and make them viable for the circular economy, even in the mature ones. Overall, we identify that regardless of the alternative, in particular those not vastly implemented, future investigations should prioritize: (1) The capacity to remove selected pollutants and decrease impurities; (2) energy recovery and efficiency; (3) environmental safety; (4) economic viability and industrial implementation; (5) hybridization; and (6) sustainability through waste processing.
- Published
- 2023
- Full Text
- View/download PDF
8. 507 - REINFECCIONES POR COVID-19 EN PROFESIONALES SANITARIOS DURANTE LOS PRIMEROS DOS AÑOS DE PANDEMIA
- Author
-
Romero, José Andrés Marchena, Mayer, Erick F., Jareño, Mari Cruz Rodríguez, Pérez, Inma Sánchez, and Díez-Canseco, Anabel Martín-Urda
- Published
- 2023
- Full Text
- View/download PDF
9. Hypercoagulability status, operative mortality, and long-term survival in patients operated on for mesenteric venous thrombosis
- Author
-
Acosta-Mérida, María Asunción, Ortiz-López, David, Suárez-Cabrera, Aurora, Pelloni, María, Rahy-Martín, Aída Cristina, Bañolas-Suárez, Raquel, and Marchena-Gómez, Joaquín
- Abstract
Mesenteric venous thrombosis (MVT) is a rare cause of acute surgical abdomen, with high mortality. The aim of this study was to analyze long-term outcomes and possible factors influencing its prognosis.
- Published
- 2023
- Full Text
- View/download PDF
10. 796 - SEGUIMIENTO DE PACIENTES CON ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA (EPOC) EN UNA UNIDAD DE PACIENTE CRÓNICO COMPLEJO (UPCC) MEDIANTE UNA HERRAMIENTA DE INTELIGENCIA ARTIFICIAL
- Author
-
Rivas, Mari Cruz Almendros, Oliveras, Marc Pérez, Savall, Roca Toda, Barrios, Susana Plaja, Viñals, Alba Lara, Diez-Canseco, Anabel Martín-Urda, González, Fátima Fernández, and Romero, José Marchena
- Published
- 2024
- Full Text
- View/download PDF
11. 571 - BROTE DE TUBERCULOSIS PULMONAR PRE-XDR EN CATALUÑA
- Author
-
Cazorla, Jesica Arias, González, Fátima Fernández, Romero, José Andrés Marchena, Liendo, Isis Gómez, Caamaño, Jorge García, Savall, Roca Toda, Rivas, Mari Cruz Almendros, and Diez-Canseco, Anabel Martín-Urda
- Published
- 2024
- Full Text
- View/download PDF
12. 166 - ROL DE LA ECOGRAFÍA CLÍNICA EN LA RECLASIFICACIÓN DEL RIESGO CARDIOVASCULAR EN PERSONAS QUE VIVEN CON VIH
- Author
-
Romero, José Andrés Marchena, Fidalgo, Arántzazu Mera, González, Fátima Fernández, Planas, Laura Moreto, and de la Roca Toda Savall, María
- Published
- 2024
- Full Text
- View/download PDF
13. Automatic and portable cleaning photovoltaic solar panels mechanism
- Author
-
Reategui-Ordoñez, Fulton Carlos, Marchena, Fernando Paredes, Reategui-Ordoñez, Juan Eduardo, and Pacheco, Hugo Guillermo Jimenez
- Abstract
This research designed and built an automatic and portable cleaning mechanism for photovoltaic panels (PVs). The climate variation defined the amount of accumulated dust; this modified the load efficiency (η) by 11.05% on average, reaching a maximum of 39.6% in the hour of greatest solar spectrum. The highest value obtained of fill factor (FF) was 0.29 with a clean PV compared to 0.25 of a dirty PV, in all measurements the dust decreases the FF. In this study the power (W) loss should not be greater than 2.17 W, which can be because of dirty panels with dust; and the FF greater than 71%. The amount of accumulated dust decreases the FF, for this reason the cleaning mechanism must be programmable, must be portable and adjustable to different PV sizes.
- Published
- 2023
- Full Text
- View/download PDF
14. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial
- Author
-
Bhatt, Deepak L, Vaduganathan, Muthiah, Kandzari, David E, Leon, Martin B, Rocha-Singh, Krishna, Townsend, Raymond R, Katzen, Barry T, Oparil, Suzanne, Brar, Sandeep, DeBruin, Vanessa, Fahy, Martin, Bakris, George L, Bhatt, Deepak L, Bakris, George, Cohen, Sidney A, D'Agostino, Ralph, Esler, Murray, Flack, John, Kandzari, David E, Katzen, Barry, Leon, Martin, Mauri, Laura, Negoita, Manuela, Oparil, Suzanne, Rocha-Singh, Krishna, Townsend, Ray, Abbud, Ziad, Addo, Tayo, Anderson, David, Angle, John, Aronow, Herbert, Babaev, Anvar, Benzuly, Keith, Brar, Somjot, Brown, David, Calhoun, David, Casale, Paul, Chaffer, Sheldon, Choi, James, Chung, Eugene, Cohen, Debbie L, Creager, Mark, Dangas, George, Dauerman, Harold, David, Shukri, Davies, Mark, de Marchena, Eduardo, Denktas, Ali E, Devireddy, Chandan, Downey, William, Dunlap, Mark, Fisher, Daniel, Flack, John, Ghali, Magdi, Gnall, Eric, Gollapudi, Raghava, Goodwin, Mark, Goswami, Nilesh, Gruberg, Luis, Gulati, Rajiv, Gupta, Anuj, Gupta, Anjan, Gurm, Hitinder, Hastings, Jeffrey, Kinlay, Scott, Kipperman, Robert, Buchbinder, Maurice, Kirtane, Ajay, Kovach, Richard, Lee, David, Mann, Samuel, Marso, Steven, Matar, Fadi, Mazzaferri, Ernest, Mandelsohn, Farrel, Moussa, Issam, Murphy, Timothy, Nathan, Sandeep, Negus, Brian, Parikh, Sahil, Patel, Manesh, Patel, Kirikumar, Paulus, Basil, Petrossian, George, Powell, Alex, Preibisz, Jacek, Rader, Florian, Randall, Otelio, Razavi, Mahmood, Reilly, John, Reiner, Jonathan, Ring, Michael, Robbins, Mark, Rogers, Kevin, Ruggiero, Nicolas, Santos, Renato, Little, William, Schindler, John, Scott, Thomas, Shimshak, Thomas, Shishehbor, Mehdi, Silver, Mitchel, Singh, Jasvindar, Singh, Kanwar, Slovut, David, Stoufer, Rick G, Teirsten, Paul, Todoran, Thomas, Vetrovec, George, Waksman, Ron, Wang, Yale, Waxman, Sergio, Wilkins, Robert, Ziada, Khaled, and Zidar, Frank
- Abstract
The SYMPLICITY HTN-3 (Renal Denervation in Patients With Uncontrolled Hypertension) trial showed the safety but not efficacy of the Symplicity system (Medtronic, Santa Rosa, CA, USA) at 6 months follow-up in patients with treatment-resistant hypertension. This final report presents the 36-month follow-up results.
- Published
- 2022
- Full Text
- View/download PDF
15. Situación actual y retos de los pediatras españoles en el manejo del dolor infantil
- Author
-
Mozo del Castillo, Yasmina, Toledo del Castillo, Blanca, Navarro Marchena, Lucía, Leyva Carmona, Moisés, Monfort Carretero, Laura, Míguez Navarro, María Concepción, and Marsinyach Ros, Itziar
- Abstract
El dolor en Pediatría es un síntoma con frecuencia infradiagnosticado y deficientemente tratado a pesar de su prevalencia, siendo el déficit de conocimientos de los pediatras una de las barreras para garantizar un manejo eficaz. El presente trabajo describe el escenario actual y los retos en el abordaje diagnóstico y terapéutico del dolor infantil por pediatras en nuestro medio. Los resultados se obtienen de un estudio transversal descriptivo que se realiza entre octubre de 2021 y marzo de 2022 mediante encuesta de difusión a pediatras españoles diseñada por el Grupo Español para el Estudio de Dolor Pediátrico. Se pone el foco especialmente en las oportunidades de formación en diferentes aspectos del dolor pediátrico.
- Published
- 2022
- Full Text
- View/download PDF
16. Tamizaje del trastorno por déficit de atención e hiperactividad (TDAH) en pacientes hospitalizados por farmacodependencia en una unidad de salud mental en Barranquilla, Colombia
- Author
-
Gutierrez-Marchena, Natalia, Padilla-Menco, Anderson David, and Ruiz-Plaza, Dania Lucía
- Abstract
El trastorno por déficit de atención e hiperactividad (TDAH) se considera un trastorno en el neurodesarrollo que se presenta normalmente en la infancia y puede continuar a la adultez. Afecta principalmente 3 áreas dadas por la atención, el control de impulsos y la hiperactividad, los cuales terminan afectando el desarrollo psicosocial, relaciones interpersonales y nivel académico del sujeto. La prevalencia varía dependiendo del grupo etario, sexo y lugar; sin embargo, se estima en un 7% global en la población pediátrica y persiste en un 4,5% en los adultos. Se ha encontrado que los síntomas del TDAH predicen el consumo de tabaco, alcohol y cannabis y, adicionalmente, de no ser tratado, se estima que hasta el 50% de las personas con TDAH manifestarán un trastorno por uso de sustancias (TUS) en algún momento de su vida; sin embargo, no se tienen datos de dicha comorbilidad en nuestra población, por lo que consideramos necesario determinar la prevalencia del TDAH en la población hospitalizada por TUS en la unidad de salud mental mediante el tamizaje con escalas de autorreporte. Aquí, reportamos la caracterización sociodemográfica, el patrón de consumo y las comorbilidades de dicha población, así como el resultado del tamizaje con las escalas Wender Utah (WURS-25) y Adult ADHD Self Report Scale (ASRS V1.1). El estudio incluyó un total de 74 sujetos que se encontraban hospitalizados en una unidad de salud mental localizado en Barranquilla, Atlántico, Colombia, con diagnóstico de TUS. Se encontró que el 50% de los pacientes puntúa positivos para diagnóstico de TDAH según la escala ASRS, diagnóstico probable 20,3% y poco probable el 29,7%, con un 44,6% de positivos en la escala WURS-25. Los resultados del presente estudio sugieren que el tamizaje para el TDAH es una herramienta útil para detectar la comorbilidad en aquellos pacientes que presentan un TUS, los cuales podrían ser beneficiados con un tratamiento integral para ambas enfermedades y así impactar en el curso y pronóstico de la enfermedad, como en su funcionalidad y calidad de vida.
- Published
- 2025
- Full Text
- View/download PDF
17. 149 - ESTUDIO DESCRIPTIVO DE LA TROMBOFILIA EN LA UNIDAD DE ENFERMEDAD TROMBOEMBÓLICA DE UN HOSPITAL COMARCAL
- Author
-
Cavallazzi, Nicolas Ruiz, Yglesias, Pablo Javier Marchena, Sanso, Gemma Donaire, Zott, Elena Sophie, Barrera, María José Castillo, de Freitas, Nadine Khan, Darias, Sandro Herrera, and Redrado, Xavier Martret
- Published
- 2024
- Full Text
- View/download PDF
18. Valor del Ratio Neutrófilo-Linfocito, Ratio Plaqueta-Linfocito y Proteína CReactiva del primer día como predictores de complicaciones postoperatorias tras cirugía oncológica gástrica
- Author
-
Ortiz-López, D., Acosta-Mérida, M.A., Casimiro-Pérez, J.A., Silvestre-Rodríguez, J., and Marchena-Gómez, J.
- Abstract
La Relación Neutrófilo-Linfocito (NLR, por sus siglas en inglés «Neutrophil-to-Lymphocyte Ratio»), la Relación Plaqueta-Linfocito (PLR, por sus siglas en inglés «Platelet-to-Lymphocyte Ratio») y la Proteína C Reactiva (PCR) son parámetros analíticos sencillos que pueden informarnos sobre el estado inflamatorio del organismo. La PCR ha mostrado ser predictor de complicaciones postoperatorias, mientras la NLR y la PLR han mostrado mayor utilidad en el pronóstico de patologías oncológicas.
- Published
- 2022
- Full Text
- View/download PDF
19. Macrophages aggregate and phase separate when activated via Fc receptors or inflammatory cytokines
- Author
-
Dooling, Lawrence J., Ontko, Nicholas, Marchena, Tristan, and Discher, Dennis E.
- Published
- 2024
- Full Text
- View/download PDF
20. Incidence, Clinical Characteristics, Risk Factors, and Outcomes of Upper Gastrointestinal Bleeding in Patients With COVID-19
- Author
-
González González, Rebeca, Jacob, Javier, Miró, Òscar, Llorens, Pere, Jiménez, Sònia, González del Castillo, Juan, Burillo-Putze, Guillermo, Martín, Alfonso, Martín-Sánchez, Francisco J., Lamberechts, Jorge G., Alquézar-Arbé, Aitor, Higa-Sansone, Leopoldo, Gayoso Martín, Sara, Carbajosa, Virginia, Beddar Chaib, Fahd, Salido, Manuel, Marchena González, María J., Calvo López, Ricardo, González Martínez, Félix, Pavón Monzo, José, Velarde Herrera, Desiré M., Niembro Valdés, Ana P., Quero Motto, Eva, Ferreras Amez, José M., and Piñera-Salmerón, Pascual
- Published
- 2022
- Full Text
- View/download PDF
21. Clinical characteristics and outcomes of invasively ventilated patients with COVID-19 in Argentina (SATICOVID): a prospective, multicentre cohort study
- Author
-
Estenssoro, Elisa, Loudet, Cecilia I, Ríos, Fernando G, Kanoore Edul, Vanina S, Plotnikow, Gustavo, Andrian, Macarena, Romero, Ignacio, Piezny, Damián, Bezzi, Marco, Mandich, Verónica, Groer, Carla, Torres, Sebastián, Orlandi, Cristina, Rubatto Birri, Paolo N, Valenti, María F, Cunto, Eleonora, Sáenz, María G, Tiribelli, Norberto, Aphalo, Vanina, Reina, Rosa, Dubin, Arnaldo, Estenssoro, E, Dubin, A, Loudet, C I, Ríos, F, Kanoore Edul, V S, Plotnikow, G, Reina, R, Andrian, M, Ivacachi, J, Romero, I, Garay, C, Piezny, D, Sagardía, J, Bezzi, M, Borello, S, Mandich, V, Chiacchiara, D, Groer, C, García Almirón, C, Kovac, A, Torres, S, Cesio, C, Orlandi, C, Hernández, R, Rubatto Birri, P N, Mugno, M, Valenti, M F, Gómez, R A, Cunto, E, Chediack, V, Sáenz, M G, Marchena, C, Tiribelli, N, Guaymas, M, Aphalo, V, Vázquez, D, Saad, Y, Sánchez, D, Iglesias, F, Casteluccio, P, Lattanzio, B, Eiguren, S, Noval, D, Fredes, S, Izzo, G C, Cabrera, H, Pozo, M O, Sac, S, Tornatore, N, Sakugawa, J, Villafañe, C, Di Sibio, A, Maskin, P, Rodríguez, P, Nihany, N, Mogadouro, M, Pálizas (h), F, Cornú, E, Esperatti, M, Pintos, J M, Badariotti, G, Echevarría, G, Mazzola, A M, Giuggia, C, Dargains, N, Turano, A, Pugliese, F, Zec Baskarad, M J, Chamadoira, M, Medina, J C, Búsico, M, Villarejo, F, Collazos, H, Huanca, T, Pendino, J C, Talamonti, L, Skrzypiec, F, Tascón, C, Genovese, G, Alul, H, Zavattieri, A, Herrera, A J, Rosales, N, Quintana, M G, Risso Vazquez, A, Lugaro, M, Díaz Rousseaux, E, Falcone, M, Kurban, F, Cini, M, Zakalik, G, Pellegrini, C, Fernández, G, Sottile, J P, Barrios, S, Hamada, O, Mendiluce, V, Villalba, D, Sacco, F, Mezzina, V, Servin, C, Quinteros, M, Nuñez, H, Campassi, M L, Banegas, D, Balasini, C, Leiva, V, Maicol, F, Domeniconi, G, Vilaseca, V, Barrientos, A, Larocca, F, Kumar, L, Luna, R, Deheza Lonardi, M, Oholeguy, A, Carnero Echegaray, J, Marazzi, C, Helca Regis, P, Rópolo, F, Bobadilla, A, Thomas, V, Funes Nelson, N, Villavicencio, C, Machare, P, Aramayo, N, González, C, Ferriccioni, M, and Bergesio, J
- Abstract
Although COVID-19 has greatly affected many low-income and middle-income countries, detailed information about patients admitted to the intensive care unit (ICU) is still scarce. Our aim was to examine ventilation characteristics and outcomes in invasively ventilated patients with COVID-19 in Argentina, an upper middle-income country.
- Published
- 2021
- Full Text
- View/download PDF
22. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study
- Author
-
Blondon, Marc, Jimenez, David, Robert‐Ebadi, Helia, Del Toro, Jorge, Lopez‐Jimenez, Luciano, Falga, Conxita, Skride, Andris, Font, Llorenç, Vazquez, Fernando Javier, Bounameaux, Henri, Monreal, Manuel, Prandoni, Paolo, Brenner, Benjamin, Farge‐Bancel, Dominique, Barba, Raquel, Di Micco, Pierpaolo, Bertoletti, Laurent, Schellong, Sebastian, Tzoran, Inna, Reis, Abilio, Bosevski, Marijan, Malý, Radovan, Verhamme, Peter, Caprini, Joseph A, My Bui, Hanh, Adarraga, MD, Agud, M, Aibar, J, Aibar, MA, Alfonso, J, Amado, C, Arcelus, JI, Baeza, C, Ballaz, A, Barba, R, Barbagelata, C, Barrón, M, Barrón‐Andrés, B, Blanco‐Molina, A, Botella, E, Camon, AM, Castro, J, Caudevilla, MA, Cerdà, P, Chasco, L, Criado, J, de Ancos, C, de Miguel, J, Demelo‐Rodríguez, P, Díaz‐Peromingo, JA, Díez‐Sierra, J, Díaz‐Simón, R, Domínguez, IM, Encabo, M, Escribano, JC, Falgá, C, Farfán, AI, Fernández‐Capitán, C, Fernández‐Reyes, JL, Fidalgo, MA, Flores, K, Font, C, Francisco, I, Gabara, C, Galeano‐Valle, F, García, MA, García‐Bragado, F, García‐Mullor, MM, Gavín‐Blanco, O, Gavín‐Sebastián, O, Gil‐Díaz, A, Gómez‐Cuervo, C, González‐Martínez, J, Grau, E, Guirado, L, Gutiérrez, J, Hernández‐Blasco, L, Jara‐Palomares, L, Jaras, MJ, Jiménez, D, Joya, MD, Jou, I, Lacruz, B, Lecumberri, R, Lima, J, Lobo, JL, López‐Brull, H, López‐Jiménez, L, López‐Miguel, P, López‐Núñez, JJ, López‐Reyes, R, López‐Sáez, JB, Lorente, MA, Lorenzo, A, Loring, M, Madridano, O, Maestre, A, Marchena, PJ, Martín del Pozo, M, Martín‐Martos, F, Martínez‐Baquerizo, C, Mella, C, Mellado, M, Mercado, MI, Moisés, J, Morales, MV, Muñoz‐Blanco, A, Muñoz‐Guglielmetti, D, Muñoz‐Rivas, N, Nart, E, Nieto, JA, Núñez, MJ, Olivares, MC, Ortega‐Michel, C, Ortega‐Recio, MD, Osorio, J, Otalora, S, Otero, R, Parra, P, Parra, V, Pedrajas, JM, Pellejero, G, Pérez‐Jacoiste, A, Peris, ML, Pesántez, D, Porras, JA, Portillo, J, Reig, L, Riera‐Mestre, A, Rivas, A, Rodríguez‐Cobo, A, Rodríguez‐Matute, C, Rogado, J, Rosa, V, Rubio, CM, Ruiz‐Artacho, P, Ruiz‐Giménez, N, Ruiz‐Ruiz, J, Ruiz‐Sada, P, Sahuquillo, JC, Salgueiro, G, Sampériz, A, Sánchez‐Muñoz‐Torrero, JF, Sancho, T, Sigüenza, P, Sirisi, M, Soler, S, Suárez, S, Suriñach, JM, Tiberio, G, Torres, MI, Tolosa, C, Trujillo‐Santos, J, Uresandi, F, Usandizaga, E, Valle, R, Vela, JR, Vidal, G, Vilar, C, Villares, P, Zamora, C, Gutiérrez, P, Vázquez, FJ, Vanassche, T, Vandenbriele, C, Verhamme, P, Hirmerova, J, Malý, R, Salgado, E, Benzidia, I, Bertoletti, L, Bura‐Riviere, A, Crichi, B, Debourdeau, P, Espitia, O, Farge‐Bancel, D, Helfer, H, Mahé, I, Moustafa, F, Poenou, G, Schellong, S, Braester, A, Brenner, B, Tzoran, I, Amitrano, M, Bilora, F, Bortoluzzi, C, Brandolin, B, Ciammaichella, M, Colaizzo, D, Dentali, F, Di Micco, P, Giammarino, E, Grandone, E, Mangiacapra, S, Mastroiacovo, D, Maida, R, Mumoli, N, Pace, F, Pesavento, R, Pomero, F, Prandoni, P, Quintavalla, R, Rocci, A, Siniscalchi, C, Tufano, A, Visonà, A, Vo Hong, N, Zalunardo, B, Kalejs, RV, Maķe, K, Ferreira, M, Fonseca, S, Martins, F, Meireles, J, Bosevski, M, Zdraveska, M, Mazzolai, L, Caprini, JA, Tafur, AJ, Weinberg, I, Wilkins, H, and Bui, HM
- Abstract
Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non‐massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non‐massive PE during anticoagulation and after its discontinuation. We included all participants in the RIETE registry who suffered a symptomatic, objectively confirmed segmental or more central PE. Massive PE was defined by a systolic hypotension at clinical presentation (<90 mm Hg). We compared the risks of recurrent VTE, major bleeding, and mortality using time‐to‐event multivariable competing risk modeling. There were 3.5% of massive PE among 38 996 patients with PE. During the anticoagulation period, massive PE was associated with a greater risk of major bleeding (subhazard ratio [sHR] 1.72, 95% confidence interval [CI] 1.28–2.32), but not of recurrent VTE (sHR 1.15, 95% CI 0.75–1.74) than non‐massive PE. An increased risk of mortality was only observed in the first month after PE. After discontinuation of anticoagulation, among 11 579 patients, massive PE and non‐massive PE had similar risks of mortality, bleeding, and recurrent VTE (sHR 0.85, 95% CI 0.51–1.40), but with different case fatality of recurrent PE (11.1% versus 2.4%, P= .03) and possibly different risk of recurrent fatal PE (sHR 3.65, 95% CI 0.82–16.24). In this large prospective registry, the baseline hemodynamic status of the incident PE did not influence the risk of recurrent VTE, during and after the anticoagulation periods, but was possibly associated with recurrent PE of greater severity.
- Published
- 2021
- Full Text
- View/download PDF
23. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study
- Author
-
Blondon, Marc, Jimenez, David, Robert‐Ebadi, Helia, Del Toro, Jorge, Lopez‐Jimenez, Luciano, Falga, Conxita, Skride, Andris, Font, Llorenç, Vazquez, Fernando Javier, Bounameaux, Henri, Monreal, Manuel, Prandoni, Paolo, Brenner, Benjamin, Farge‐Bancel, Dominique, Barba, Raquel, Di Micco, Pierpaolo, Bertoletti, Laurent, Schellong, Sebastian, Tzoran, Inna, Reis, Abilio, Bosevski, Marijan, Malý, Radovan, Verhamme, Peter, Caprini, Joseph A, My Bui, Hanh, Adarraga, MD, Agud, M, Aibar, J, Aibar, MA, Alfonso, J, Amado, C, Arcelus, JI, Baeza, C, Ballaz, A, Barba, R, Barbagelata, C, Barrón, M, Barrón‐Andrés, B, Blanco‐Molina, A, Botella, E, Camon, AM, Castro, J, Caudevilla, MA, Cerdà, P, Chasco, L, Criado, J, de Ancos, C, de Miguel, J, Demelo‐Rodríguez, P, Díaz‐Peromingo, JA, Díez‐Sierra, J, Díaz‐Simón, R, Domínguez, IM, Encabo, M, Escribano, JC, Falgá, C, Farfán, AI, Fernández‐Capitán, C, Fernández‐Reyes, JL, Fidalgo, MA, Flores, K, Font, C, Francisco, I, Gabara, C, Galeano‐Valle, F, García, MA, García‐Bragado, F, García‐Mullor, MM, Gavín‐Blanco, O, Gavín‐Sebastián, O, Gil‐Díaz, A, Gómez‐Cuervo, C, González‐Martínez, J, Grau, E, Guirado, L, Gutiérrez, J, Hernández‐Blasco, L, Jara‐Palomares, L, Jaras, MJ, Jiménez, D, Joya, MD, Jou, I, Lacruz, B, Lecumberri, R, Lima, J, Lobo, JL, López‐Brull, H, López‐Jiménez, L, López‐Miguel, P, López‐Núñez, JJ, López‐Reyes, R, López‐Sáez, JB, Lorente, MA, Lorenzo, A, Loring, M, Madridano, O, Maestre, A, Marchena, PJ, Martín del Pozo, M, Martín‐Martos, F, Martínez‐Baquerizo, C, Mella, C, Mellado, M, Mercado, MI, Moisés, J, Morales, MV, Muñoz‐Blanco, A, Muñoz‐Guglielmetti, D, Muñoz‐Rivas, N, Nart, E, Nieto, JA, Núñez, MJ, Olivares, MC, Ortega‐Michel, C, Ortega‐Recio, MD, Osorio, J, Otalora, S, Otero, R, Parra, P, Parra, V, Pedrajas, JM, Pellejero, G, Pérez‐Jacoiste, A, Peris, ML, Pesántez, D, Porras, JA, Portillo, J, Reig, L, Riera‐Mestre, A, Rivas, A, Rodríguez‐Cobo, A, Rodríguez‐Matute, C, Rogado, J, Rosa, V, Rubio, CM, Ruiz‐Artacho, P, Ruiz‐Giménez, N, Ruiz‐Ruiz, J, Ruiz‐Sada, P, Sahuquillo, JC, Salgueiro, G, Sampériz, A, Sánchez‐Muñoz‐Torrero, JF, Sancho, T, Sigüenza, P, Sirisi, M, Soler, S, Suárez, S, Suriñach, JM, Tiberio, G, Torres, MI, Tolosa, C, Trujillo‐Santos, J, Uresandi, F, Usandizaga, E, Valle, R, Vela, JR, Vidal, G, Vilar, C, Villares, P, Zamora, C, Gutiérrez, P, Vázquez, FJ, Vanassche, T, Vandenbriele, C, Verhamme, P, Hirmerova, J, Malý, R, Salgado, E, Benzidia, I, Bertoletti, L, Bura‐Riviere, A, Crichi, B, Debourdeau, P, Espitia, O, Farge‐Bancel, D, Helfer, H, Mahé, I, Moustafa, F, Poenou, G, Schellong, S, Braester, A, Brenner, B, Tzoran, I, Amitrano, M, Bilora, F, Bortoluzzi, C, Brandolin, B, Ciammaichella, M, Colaizzo, D, Dentali, F, Di Micco, P, Giammarino, E, Grandone, E, Mangiacapra, S, Mastroiacovo, D, Maida, R, Mumoli, N, Pace, F, Pesavento, R, Pomero, F, Prandoni, P, Quintavalla, R, Rocci, A, Siniscalchi, C, Tufano, A, Visonà, A, Vo Hong, N, Zalunardo, B, Kalejs, RV, Maķe, K, Ferreira, M, Fonseca, S, Martins, F, Meireles, J, Bosevski, M, Zdraveska, M, Mazzolai, L, Caprini, JA, Tafur, AJ, Weinberg, I, Wilkins, H, and Bui, HM
- Abstract
Little is known about the prognosis of patients with massive pulmonary embolism (PE) and its risk of recurrent venous thromboembolism (VTE) compared with non‐massive PE, which may inform clinical decisions. Our aim was to compare the risk of recurrent VTE, bleeding, and mortality after massive and non‐massive PE during anticoagulation and after its discontinuation.
- Published
- 2021
- Full Text
- View/download PDF
24. Dolor inguinal crónico posquirúrgico. Una revisión narrativa
- Author
-
Medina Velázquez, Raúl, Marchena Gómez, Joaquín, and Luque García, María José
- Published
- 2021
- Full Text
- View/download PDF
25. Una complicación del cierre endoscópico de perforación duodenal con sistema OVESCO
- Author
-
Rahy-Martín, A.C., Jiménez-Díaz, L., Rodríguez-Pérez, R.M., Acosta-Mérida, M.A., and Marchena-Gómez, J.
- Published
- 2022
- Full Text
- View/download PDF
26. Clinical practice guideline for transcatheter versus surgical valve replacement in patients with severe aortic stenosis in Latin America
- Author
-
Lamelas, Pablo, Ragusa, Martin Alberto, Bagur, Rodrigo, Jaffer, Iqbal, Ribeiro, Henrique, Baranchuk, Adrian, Wyss, Fernando, Sosa Liprandi, Alvaro, Olivares, Gabriel, Arrais, Magaly, Rendon, Juan Camilo, Catrip, Jorge, Agatiello, Carla, Cura, Fernando, Marchena, Alfaro, Sandoli de Brito Jr, Fabio, Mangione, José A, Damonte, Aníbal, Santaera, Omar, Hidalgo, Pedro, Nieuwlaat, Robby, and Izcovich, Ariel
- Abstract
In elderly (75 years or older) patients living in Latin America with severe symptomatic aortic stenosis candidates for transfemoral approach, the panel suggests the use of transcatheter aortic valve implant (TAVI) over surgical aortic valve replacement (SAVR). This is a conditional recommendation, based on moderate certainty in the evidence (⨁⨁⨁Ο).This recommendation does not apply to patients in which there is a standard of care, like TAVI for patients at very high risk for cardiac surgery or inoperable patients, or SAVR for non-elderly patients (eg, under 65 years old) at low risk for cardiac surgery. The suggested age threshold of 75 years old is based on judgement of limited available literature and should be used as a guide rather than a determinant threshold.The conditional nature of this recommendation means that the majority of patients in this situation would want a transfemoral TAVI over SAVR, but some may prefer SAVR. For clinicians, this means that they must be familiar with the evidence supporting this recommendation and help each patient to arrive at a management decision integrating a multidisciplinary team discussion (Heart Team), patient’s values and preferences through shared decision-making, and available resources. Policymakers will require substantial debate and the involvement of various stakeholders to implement this recommendation.
- Published
- 2021
- Full Text
- View/download PDF
27. Mercado 84.
- Author
-
Olivo, Emilio, Julián, Rosa, Santana, Ana, and Marchena, Rocío
- Published
- 2020
28. Answering the Call
- Author
-
Mañón, Victoria A., Demian, Nagi, Aziz, Shahid R., and Marchena, Jose M.
- Abstract
Addressing access to oral health care in many low- to middle-income countries is a complicated issue. Oral and maxillofacial surgeons may help engage with vulnerable populations through carefully planned dentoalveolar mission trips. The process of planning a mission includes selecting a population and identifying their unique needs, designing clinic layouts and workflows, team preparation, collection of supplies, fundraising, and advertising. During the mission, methods for protecting privacy, delivering treatment that is standard of care, and sanitation/sterilization options are reviewed. Ethical considerations include avoiding exploitation of vulnerable populations, offending local hosts, need for data collection, and long-term mission sustainability.
- Published
- 2020
- Full Text
- View/download PDF
29. Prognostic capability of the Maximum Acute Gastrointestinal Injury Score and of caloric intake in patients requiring vasopressors: A multicenter prospective cohort study
- Author
-
Loudet, Cecilia I., Marchena, María C., Tumino, Leandro I., Cabana, María L., Capurro, Gabriela, Astegiano, Paulina, Velásquez, Mariela A., Casanova, Matías, Rodríguez Bugueiro, María J., Roth, María C., Roda, Gisela, Gimbernat, Rolando, Balmaceda, Yanina Del Valle, Okurzaty, Patricia, Perman, Mario I., González, Ana L., Reina, Rosa, and Estenssoro, Elisa
- Abstract
Our main objective was to use the Maximum Acute Gastrointestinal Injury Score (AGImax) to evaluate the prognostic capability of gastrointestinal dysfunction (GID), on hospital mortality in patients on mechanical ventilation (MV) requiring vasopressors. A secondary goal was to analyze the relationship between AGImaxand vasopressor dosage with increasing caloric intake.
- Published
- 2020
- Full Text
- View/download PDF
30. Reuse of manganese sulfate as raw material by recovery from pesticide's wastewater using nanofiltration and electro-electrodialysis: process simulation and analysis from actual data
- Author
-
Mejía Marchena, Ricardo, Maturana Córdoba, Aymer, Gomez Cerón, Diego, Quintero Monroy, Christian, Arismendy Montes, Luis, and Cardenas Perez, Carlos
- Published
- 2020
- Full Text
- View/download PDF
31. Different Types of Statins and All-Cause Mortality during Anticoagulation for Venous Thromboembolism: Validation Study from RIETE Registry
- Author
-
Siniscalchi, Carmine, Suriñach, José M., Visonà, Adriana, Fernández-Reyes, José L., Gómez-Cuervo, Covadonga, Verhamme, Peter, Marchena, Pablo J., Farge-Bancel, Dominique, Moisés, Jorge, and Monreal, Manuel
- Published
- 2020
- Full Text
- View/download PDF
32. Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism
- Author
-
Marchena, Pablo Javier, Tzoran, Inna, Brenner, Benjamin, Martín, Mar, Malý, Radovan, Bura-Riviere, Alessandra, Valle, Reina, Hernández-Blasco, Luis, López-Sáez, Juan Bosco, and Monreal, Manuel
- Published
- 2020
- Full Text
- View/download PDF
33. Solid tumor cohesion and growth are overcome in phagocytosis by SIRPα-knockout macrophages
- Author
-
Marchena, Tristan, Dooling, Lawrence J., Ontko, Nicholas, Andrechak, Jason C., and Discher, Dennis E.
- Published
- 2024
- Full Text
- View/download PDF
34. Evolving Technologies for Tissue Cutting
- Author
-
Jundt, Jonathon S., Marchena, Jose M., Hanna, Issa, Dhanda, Jagtar, Breit, Matthew J., and Perry, Andrew P.
- Abstract
This article reviews evolving and lesser known technologies for tissue cutting and their application in oral and maxillofacial surgery.
- Published
- 2019
- Full Text
- View/download PDF
35. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
- Author
-
Haas, Sylvia, Ageno, Walter, Weitz, Jeffrey I., Goldhaber, Samuel Z., Turpie, Alexander G.G., Goto, Shinya, Angchaisuksiri, Pantep, Dalsgaard Nielsen, Joern, Kayani, Gloria, Zaghdoun, Audrey, Farjat, Alfredo E., Schellong, Sebastian, Bounameaux, Henri, Mantovani, Lorenzo G., Prandoni, Paolo, Kakkar, Ajay K., Loualidi, Ab, Colak, Abdurrahim, Bezuidenhout, Abraham, Abdool‐Carrim, Abu, Azeddine, Addala, Beyers, Adriaan, Dees, Adriaan, Mohamed, Ahmed, Aksoy, Ahmet, Abiko, Akihiko, Watanabe, Akinori, Krichell, Alan, Fernandez, Alberto Alfredo, Tosetto, Alberto, Khotuntsov, Alexey, Oropallo, Alisha, Slocombe, Alison, Kelly, Allan, Clark, Amanda, Gad, Amr, Arouni, Amy, Schmidt, Andor, Berni, Andrea, Kleiban, Andres Javier, Machowski, Andrew, Kazakov, Andrey, Galvez, Angel, Lockman, Ann, Falanga, Anna, Chauhan, Anoop, Riera‐Mestre, Antoni, Mazzone, Antonino, D'Angelo, Armando, Herdy, Artur, Kato, Atsushi, Ebrahim, Ayman Abd Elhamid, Salem, Mahmoud, Husin, Azlan, Erdelyi, Barbara, Jacobson, Barry, Amann‐Vesti, Beatrice, Battaloglu, Bektas, Wilson, Benedicte, Cosmi, Benilde, Francois, Bergmann Jean, Toufek, Berremeli, Hunt, Beverley, Natha, Bhavesh, Mustafa, Bisher, Kho, Bonnie Chi Shan, Carine, Boulon, Zidel, Brian, Dominique, Brisot, Christophe, Brousse, Trimarco, Bruno, Luo, Canhua, Alberto Cuneo, Carlos, Sanchez Diaz, Carlos Jerjes, Schwencke, Carsten, Cader, Cas, Yavuz, Celal, Javier Zaidman, Cesar, Lunn, Charles, Wu, Chau‐Chung, Toh, Cheng Hock, Chiang, Chern‐En, Elisa, Chevrier, Hsia, Chien‐Hsun, Huang, Chien‐Lung, Kwok, Chi‐Hang Kevin, Wu, Chih‐Cheng, Huang, Chi‐Hung, Ward, Chris, Opitz, Christian, Jeanneret‐Gris, Christina, Ha, Chung Yin, Huang, Chun‐Yao, Bidi, Claude Luyeye, Smith, Clifford, Brauer, Cornelia, Lodigiani, Corrado, Francis, Couturaud, Wu, Cynthia, Staub, Daniel, Theodoro, Daniel, Poli, Daniela, Acevedo, Riesco, Adler, David, Jimenez, David, Keeling, David, Scott, David, Imberti, Davide, Creagh, Desmond, Helene, Desmurs‐Clavel, Hagemann, Dirk, Le Roux, Dirk, Skowasch, Dirk, Belenky, Dmitry, Dorokhov, Dmitry, Petrov, Dmitry, Zateyshchikov, Dmitry, Prisco, Domenico, Møller, Dorthe, Kucera, Dusan, Esheiba, Ehab M., Panchenko, Elizaveta, Dominique, Elkouri, Dogan, Emre, Kubat, Emre, Diaz Diaz, Enrique, Tse, Eric Wai Choi, Yeo, Erik, Hashas, Erman, Grochenig, Ernst, Tiraferri, Eros, Blessing, Erwin, Michèle, Escande Orthlieb, Usandizaga, Esther, Porreca, Ettore, Ferroni, Fabian, Nicolas, Falvo, Ayala‐Paredes, Félix, Koura, Firas, Henry, Fitjerald, Cosmi, Franco, Erdkamp, Frans, Kamalov, Gadel, Dalmau, Garcia‐Bragado, Damien, Garrigues, Klein, Garry, Shah, Gaurand, Hollanders, Geert, Merli, Geno, Plassmann, Georg, Platt, George, Poirier, Germain, Sokurenko, German, Haddad, Ghassan, Ali, Gholam, Agnelli, Giancarlo, Gan, Gin Gin, Kaye‐Eddie, Grace, Le Gal, Gregoire, Allen, Gregory, Llamas Esperón, Guillermo Antonio, Jean‐Paul, Guillot, Gerofke, Hagen, Elali, Hallah, Burianova, Hana, Ohler, Hans‐Juergen, Wang, Haofu, Darius, Harald, Gogia, Harinder S., Striekwold, Harry, Gibbs, Harry, Hasanoglu, Hatice, Turker, Hatice, Franow, Hendrik, De Raedt, Herbert, Schroe, Herman, ElDin, Hesham Salah, Zidan, Hesham, Nakamura, Hiroaki, Kim, Ho Young, Lawall, Holger, Zhu, Hong, Tian, Hongyan, Yhim, Ho‐Young, ten Cate, Hugo, Hwang, Hun Gyu, Shim, Hyeok, Kim, Igor, Libov, Igor, Sonkin, Igor, Suchkov, Igor, Song, Ik‐Chan, Kiris, Ilker, Staroverov, Ilya, Looi, Irene, De La Azuela Tenorio, Isabel M, Savas, Ismail, Gordeev, Ivan, Podpera, Ivo, Lee, Jae Hoon, Sathar, Jameela, Welker, James, Beyer‐Westendorf, Jan, Kvasnicka, Jan, Vanwelden, Jan, Kim, JangYong, Svobodova, Jaromira, Gujral, Jaspal, Marino, Javier, Galvar, Javier Tristan, Kassis, Jeannine, Kuo, Jen‐Yuan, Shih, Jhih‐Yuan, Kwon, JiHyun, Joh, Jin Hyun, Park, Jin Hyun, Kim, Jin Seok, Yang, Jinghua, Krupicka, Jiri, Lastuvka, Jiri, Pumprla, Jiri, Vesely, Jiri, Carlos Souto, Joan, Antônio Correa, João, Duchateau, Johan, Fletcher, John Perry, del Toro, Jorge, del Toro, Jorge, Chavez Paez, Jorge Guillermo, Araujo Filho, Jose Dalmo, Saraiva, Jose, Diaz Peromingo, Jose Antonio, Gomez Lara, Jose, Luis Fedele, Jose, Maria Surinach, Jose, Chacko, Joseph, Antonio Muntaner, Juan, Álvarez Benitez, Juan Carlos, Hoyos Abril, Juan Moreno, Humphrey, Julian, Bono, Julio, Kanda, Junji, Boondumrongsagoon, Juree, Yiu, Kai Hang, Chansung, Kanchana, Boomars, Karin, Burbury, Kate, Kondo, Katsuhiro, Karaarslan, Kemal, Takeuchi, Kensuke, Kroeger, Knut, Zrazhevskiy, Konstantin, Svatopluk, Koscál, Shyu, Kou‐Gi, Vandenbosch, Kristel, Chang, Kuan‐Cheng, Chiu, Kuan‐Ming, Jean‐Manuel, Kubina, Wern, Kwan Jing, Ueng, Kwo‐Chang, Norasetthada, Lalita, Binet, Laure, Chew, Lee Ping, Zhang, Lei, Cristina, Leone Maria, Tick, Lidwine, Beatriz Schiavi, Lilia, Wong, Lily Lee Lee, Borges, Lohana, Botha, Louis, Capiau, Luc, Timmermans, Luc, Eduardo López, Luciano, Ria, Luigi, Hernandez Blasco, Luis Manuel, Guzman, Luis Alberto, Flota Cervera, Luis, Isabelle, Mahe, Monreal Bosch, Manuel, de los Rios Ibarra, Manuel, Núñez Fernandez, Manuel, Carrier, Marc, Raul Barrionuevo, Marcelo, Alcocer Gamba, Marco Antonio, Cattaneo, Marco, Moia, Marco, Bowers, Margaret, Chetanachan, Mariam, Berli, Mario Alberto, Fixley, Mark, Faghih, Markus, Stuecker, Markus, Schul, Marlin, Banyai, Martin, Koretzky, Martin, Myriam, Martin, Gaffney, Mary Elizabeth, Hirano, Masao, Kanemoto, Masashi, Nakamura, Mashio, Tahar, Mersel, Emmanuel, Messas, Kovacs, Michael, Leahy, Michael, Levy, Michael, Munch, Michael, Olsen, Michael, De Pauw, Michel, Gustin, Michel, Van Betsbrugge, Michiel, Boyarkin, Mikhail, Homza, Miroslav, Koto, Modise, Abdool‐Gaffar, Mohamed, Nagib, Mohamed Ayman Fakhry, El‐Dessoki, Mohamed, Khan, Mohamed, Mohamed, Monniaty, Kim, Moo Hyun, Lee, Moon‐Hee, Soliman, Mosaad, Ahmed, Mostafa Shawky, el Bary, Mostafa Soliman Abd, Moustafa, Moustafa A., Hameed, Muhammad, Kanko, Muhip, Majumder, Mujibur, Zubareva, Nadezhda, Mumoli, Nicola, Abdullah, Nik Azim Nik, Makruasi, Nisa, Paruk, Nishen, Kanitsap, Nonglak, Duda, Norberto, Nordin, Nordiana, Nyvad, Ole, Barbarash, Olga, Gurbuz, Orcun, Vilamajo, Oscar Gomez, Nandayapa Flores, Oscar, Gur, Ozcan, Oto, Oztekin, Javier Marchena, Pablo, Carroll, Patrick, Lang, Pavel, MacCallum, Peter, von Bilderling, Peter Baron, Blombery, Peter, Verhamme, Peter, Jansky, Petr, Bernadette, Peuch, De Vleeschauwer, Philippe, Hainaut, Philippe, Ferrini, Piera Maria, Iamsai, Piriyaporn, Christian, Ponchaux, Viboonjuntra, Pongtep, Rojnuckarin, Ponlapat, Ho, Prahlad, Mutirangura, Pramook, Wells, Rachel, Martinez, Rafael, Miranda, Raimundo Tirado, Kroening, Ralf, Ratsela, Rapule, Reyes, Raquel Lopez, Diaz de Leon, Raul Franco, Wong, Raymond Siu Ming, Alikhan, Raz, Jerwan‐Keim, Reinhold, Otero, Remedios, Murena‐Schmidt, Renate, Canevascini, Reto, Ferkl, Richard, White, Richard, Van Herreweghe, Rika, Santoro, Rita, Klamroth, Robert, Mendes, Robert, Prosecky, Robert, Cappelli, Roberto, Spacek, Rudolf, Singh, Rupesh, Griffin, Sam, Na, Sang Hoon, Chunilal, Sanjeev, Middeldorp, Saskia, Nakazawa, Satoshi, Toh, See Guan, Christophe, Seinturier, Isbir, Selim, Raymundo, Selma, Ting, Seng Kiat, Motte, Serge, Aktogu, Serir Ozkan, Donders, Servaas, Cha, Seung Ick, Nam, Seung‐Hyun, Marie‐Antoinette, Sevestre‐Pietri, Maasdorp, Shaun, Sun, Shenghua, Wang, Shenming, Essameldin, Sherif Mohamed, Sholkamy, Sherif Mohamed, Kuki, Shintaro, Yoshida, Shuichi, Matsuoka, Shunzo, McRae, Simon, Watt, Simon, Patanasing, Siriwimon, Jean‐Léopold, Siwe‐Nana, Wongkhantee, Somchai, Bang, Soo‐Mee, Testa, Sophie, Zemek, Stanislav, Behrens, Steffen, Dominique, Stephan, Mellor, Stuart, Singh, Suaran Singh Gurcharan, Datta, Sudip, Chayangsu, Sunee, Solymoss, Susan, Everington, Tamara, Abdel‐Azim, Tarek Ahmed Adel, Suwanban, Tawatchai, Adademir, Taylan, Hart, Terence, Béatrice, Terriat, Luvhengo, Thifhelimbilu, Horacek, Thomas, Zeller, Thomas, Boussy, Tim, Reynolds, Tim, Biss, Tina, Chao, Ting‐Hsing, Casabella, Tomas Smith, Onodera, Tomoya, Numbenjapon, Tontanai, Gerdes, Victor, Cech, Vladimir, Krasavin, Vladimir, Tolstikhin, Vladimir, Bax, W.A., Malek, Wagih Fawzy Abdel, Ho, Wai Khoon, Pharr, Walter, Jiang, Weihong, Lin, Wei‐Hsiang, Zhang, Weihua, Tseng, Wei‐Kung, Lai, Wen‐Ter, De Backer, Wilfried, Haverkamp, Wilhelm, Yoshida, Winston, Korte, Wolfgang, Choi, Won II, Kim, Yang‐Ki, Tanabe, Yasuhiro, Ohnuma, Yasushi, Mun, Yeung‐Chul, Balthazar, Yohan, Park, Yong, Shibata, Yoshisato, Burov, Yuriy, Subbotin, Yuriy, Coufal, Zdenek, Yang, Zhenwen, Jing, Zhicheng, Jing, Zhicheng, and Yang, Zhongqi
- Abstract
Parenteral anticoagulants and vitamin K antagonists (VKAs) have constituted the cornerstone of venous thromboembolism (VTE) treatment. Meanwhile, direct oral anticoagulants (DOACs) provide physicians with an alternative. The Global Anticoagulant Registry in the FIELD (GARFIELD)‐VTE observes real‐world treatment practices.
- Published
- 2019
- Full Text
- View/download PDF
36. Documento de posicionamiento del Grupo Español para el Estudio del Dolor Pediátrico (GEEDP) de la Asociación Española de Pediatría sobre el registro del dolor como quinta constante
- Author
-
Leyva Carmona, Moisés, Torres Luna, Raquel, Ortiz San Román, Lucia, Marsinyach Ros, Itziar, Navarro Marchena, Lucia, Mangudo Paredes, Ana Belén, and Ceano-Vivas la Calle, María
- Abstract
El Grupo Español para el Estudio del Dolor Pediátrico (GEEDP) se forma en 2017 con el objetivo de ayudar a reducir o eliminar el dolor de los neonatos, lactantes, niños y adolescentes. Ante un mismo diagnóstico de dolor, los pacientes pueden padecer dolores agudos, crónicos, por procedimientos, postoperatorio, nociceptivos, neuropáticos o mixtos. Sin una adecuada valoración clínica basada en la edad, la enfermedad de base y el tipo de dolor sospechado, este sufrimiento pasa desapercibido con demasiada frecuencia y como consecuencia es infratratado y poco prevenido. La prevalencia del dolor agudo en Pediatría es difícil de estimar y según la evidencia científica actual, podemos determinar que varía entre un 22% (dolor por procedimientos) y un 77% (dolor en los pacientes de urgencias y en las plantas de hospitalización); con relación al dolor crónico, hasta un 30% de los niños pueden padecerlo en algún momento de su vida. Entre las barreras detectadas en el diagnóstico de dolor se encuentran: la dificultad para su valoración por falta de unidad en su registro, existencia de diversas escalas de valoración (según edad y tipo de dolor) y por la ausencia de formación en manejo e interpretación de estas. A esto se puede sumar, en según qué ámbitos sanitarios, la elevada presión asistencial y las dificultades de comunicación entre profesionales y entre estos con las familias.
- Published
- 2019
- Full Text
- View/download PDF
37. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism
- Author
-
Gabara, Cristina, Aibar, Jesus, Nishimoto, Yuji, Yamashita, Yugo, Prandoni, Paolo, Barnes, Geoffrey D., Bikdeli, Behnood, Jiménez, David, Demelo-Rodríguez, Pablo, Peris, Ma Luisa, Nguyen, Son Truong, Monreal, Manuel, Agudo, P., Aibar, J., Alberich-Conesa, A., Alda-Lozano, A., Alfonso, J., Amado, C., Angelina-García, M., Arcelus, J.I., Ballaz, A., Barba, R., Barbagelata, C., Barreiro, B., Barrón, M., Barrón-Andrés, B., Bascuñana, J., Beddar-Chaib, F., Blanco-Molina, A., Caballero, J.C., Cañas, I., Castellanos, G., Chasco, L., Claver, G., Criado, J., De Juana-Izquierdo, C., Del Toro, J., Demelo-Rodríguez, P., Díaz-Pedroche, M.C., Díaz-Peromingo, J.A., Dubois-Silva, A., Escribano, J.C., Falgá, C., Fernández-Aracil, C., Fernández-Capitán, C., Fernández-Jiménez, B., Fernández-Reyes, J.L., Fidalgo, M.A., Francisco, I., Gabara, C., Galeano-Valle, F., García-Bragado, F., García-Ortega, A., Gavín-Sebastián, O., Gil-Díaz, A., Gómez-Cuervo, C., González-Munera, A., Grau, E., Guirado, L., Gutiérrez-Guisado, J., Hernández-Blasco, L., Hernández-Molina, A., Hernández-Vidal, M.J., Jara-Palomares, L., Jiménez, D., Jou, I., Joya, M.D., Lalueza, A., Lecumberri, R., Llamas, P., Lobo, J.L., López-Brull, H., López-De la Fuente, M., López-Jiménez, L., López-Miguel, P., López-Núñez, J.J., López-Ruiz, A., López-Sáez, J.B., Lorente, M.A., Lorenzo, A., Lumbierres, M., Madridano, O., Maestre, A., Marchena, P.J., Marcos, M., Martín del Pozo, M., Martín-Martos, F., Martínez-Prado, R., Maza, J.M., Mercado, M.I., Moisés, J., Molino, A., Monreal, M., Monzón, L., Morales, M.V., Muñoz-Gamito, G., Navas, M.S., Nieto, J.A., Núñez-Fernández, M.J., Olid, M., Ordieres-Ortega, L., Ortiz, M., Osorio, J., Otálora, S., Otero, R., Pacheco-Gómez, N., Pagán, J., Palomeque, A.C., Paredes, E., Parra-Rosado, P., Pedrajas, J.M., Pérez-Ductor, C., Pérez-Pinar, M., Peris, M.L., Pesce, M.L., Porras, J.A., Puchades, R., Rivas, A., Rivera-Cívico, F., Rivera-Gallego, A., Rodríguez-Cobo, A., Romero-Bruguera, M., Ruiz-Artacho, P., Salgueiro, G., Sancho, T., Sendín, V., Sigüenza, P., Soler, S., Steinherr, A., Suárez-Fernández, S., Tirado, R., Torrents-Vilar, A., Torres, M.I., Trujillo-Santos, J., Uresandi, F., Valle, R., Varona, J.F., Villalobos, A., Villares, P., Ay, C., Nopp, S., Pabinger, I., Vanassche, T., Verhamme, P., Verstraete, A., Yoo, H.H.B., Montenegro, A.C., Morales, S.N., Roa, J., Hirmerova, J., Malý, R., Varhaník, F., Bertoletti, L., Bura-Riviere, A., Catella, J., Chopard, R., Couturaud, F., Espitia, O., Le Mao, R., Leclerq, B., Mahé, I., Moustafa, F., Plaisance, L., Sarlon-Bartoli, G., Suchon, P., Versini, E., Schellong, S., Brenner, B., Dally, N., Kenet, G., Tzoran, I., Rashidi, F., Sadeghipour, P., Tahmasbi, F., Abenante, A., Barillari, G., Bilora, F., Bissacco, D., Brandolin, B., Casana, R., Ciammaichella, M., Colaizzo, D., Dentali, F., Di Micco, P., Giorgi-Pierfranceschi, M., Grandone, E., Imbalzano, E., Lambertenghi-Deliliers, D., Martini, R., Meschi, T., Negro, F., Poz, A., Prandoni, P., Simioni, P., Siniscalchi, C., Taflaj, B., Ticinesi, A., Tufano, A., Visonà, A., Zalunardo, B., Kalnina, P., Kigitovica, D., Skride, A., Zicans, M., Nishimoto, Y., Yamashita, Y., Tazi-Mezalek, Z., Fonseca, S., Marques, R., Meireles, J., Pinto, S., Bosevski, M., Zdraveska, M., Bounameaux, H., Mazzolai, L., Aujayeb, A., Bikdeli, B., Caprini, J.A., Khalil, A., Tafur, J., Weinberg, I., Bui, H.M., Nguyen, S.T., Pham, K.Q., and Tran, G.B.
- Abstract
The duration of anticoagulation for a first episode of unprovoked venous thromboembolism (VTE) should balance the likelihood of VTE recurrence against the risk of major bleeding.
- Published
- 2024
- Full Text
- View/download PDF
38. Pseudoaneurisma no traumático de la arteria cística como causa de hemobilia
- Author
-
Medina Velázquez, Raúl, Casimiro Pérez, José Antonio, Acosta Mérida, María Asunción, and Marchena Gómez, Joaquín
- Published
- 2024
- Full Text
- View/download PDF
39. Use of Eltrombopag for Post-CAR T Cytopenias: A Multi-Institutional Experience
- Author
-
Wesson, William, Ahmed, Nausheen, Davis, James A, McGann, Mary, Rashid, Aliya, Tabak, Carine, Logan, Emerson, Marchena-Burgos, Jose, Nelson, Maggie, Shune, Leyla, Hoffmann, Marc S., Abdallah, Al-Ola, and Hashmi, Hamza
- Abstract
Background: Cytopenias following chimeric antigen receptor T (CAR T) cell therapy are common and can be profound and/or prolonged, leading to increased morbidity and mortality. Supportive care is the mainstay of management but strategies to reduce the duration and severity of cytopenias have yet to be optimized. One such strategy extrapolated from experience in aplastic anemia is the use of thrombopoietin (TPO) receptor agonists, like eltrombopag. Eltrombopag has been used off-label for several years for this indication, however, limited data exists regarding the safety and efficacy of its use after CAR T-cell therapy.
- Published
- 2023
- Full Text
- View/download PDF
40. Shock cardiogénico como debut de triple paraganglioma retroperitoneal en varón de 14 años
- Author
-
Acosta-Mérida, María Asunción, Silvestre-Rodríguez, José, Hernández-Ramírez, José Miguel, Godoy, Cristian, and Marchena-Gómez, Joaquín
- Published
- 2020
- Full Text
- View/download PDF
41. Cirugía mayor ambulatoria del cáncer de mama: factores relacionados con la conversión a hospitalización convencional
- Author
-
Medina Velázquez, Raúl, Jiménez Díaz, Laura, Fernández Carrión, Jezabel, Rosas Bermúdez, Clara, Miralles Curto, Montserrat, Acosta Mérida, María Asunción, and Marchena Gómez, Joaquín
- Published
- 2019
- Full Text
- View/download PDF
42. Radioterapia intraoperatoria con Intrabeam®para el tratamiento del adenocarcinoma de páncreas resecable
- Author
-
Rahy-Martín, Aida Cristina, Cruz-Benavides, Francisco, Sánchez-Lauro, Mar, Rodríguez-Méndez, Álvaro, San Miguel, Íñigo, Lara, Pedro, and Marchena-Gómez, Joaquín
- Abstract
La aplicación de radioterapia intraoperatoria en el lecho tumoral tras la resección de un cáncer de páncreas ha demostrado ser beneficiosa en el control local de la enfermedad. El objetivo de este estudio fue valorar los resultados iniciales obtenidos tras la aplicación de una nueva modalidad de radioterapia intraoperatoria (Intrabeam®) en términos de viabilidad, seguridad y resultados a corto plazo.
- Published
- 2018
- Full Text
- View/download PDF
43. Microangiopatía trombótica en paciente con cáncer de origen desconocido
- Author
-
Castillo Ramirez, Alejandra, Burillo Lorente, José, and Marchena Yglesias, Pablo Javier
- Abstract
La microangiopatía trombótica asociada a cáncer (MTAC) comprende la presencia de anemia hemolítica microangiopática, trombocitopenia y lesión isquémica de órganos en pacientes con neoplasia de origen conocido o desconocido. Su diagnóstico es desafiante pues suele ser confundido con la púrpura trombocitopénica trombótica, que es la causa más frecuente de microangiopatía trombótica en pacientes sanos. La MTAC puede ser manifestación de la neoplasia en sí misma o manifestación de complicación de la quimioterapia, por lo que tiene un pronóstico pobre. A continuación se presenta el caso de una paciente que desarrolló MTAC en el contexto de cáncer metastásico de origen primario desconocido.
- Published
- 2018
- Full Text
- View/download PDF
44. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial
- Author
-
Lai, Zhi-Wei, Kelly, Ryan, Winans, Thomas, Marchena, Ivan, Shadakshari, Ashwini, Yu, Julie, Dawood, Maha, Garcia, Ricardo, Tily, Hajra, Francis, Lisa, Faraone, Stephen V, Phillips, Paul E, and Perl, Andras
- Abstract
Patients with systemic lupus erythematosus have T-cell dysfunction that has been attributed to the activation of the mammalian target of rapamycin (mTOR). Rapamycin inhibits antigen-induced T-cell proliferation and has been developed as a medication under the generic designation of sirolimus. We assessed safety, tolerance, and efficacy of sirolimus in a prospective, biomarker-driven, open-label clinical trial.
- Published
- 2018
- Full Text
- View/download PDF
45. A Million Steps: Developing a Health Promotion Program at the Workplace to Enhance Physical Activity
- Author
-
González-Dominguez, María Eugenia, Romero-Sánchez, José Manuel, Ares-Camerino, Antonio, Marchena-Aparicio, Jose Carlos, Flores-Muñoz, Manuel, Infantes-Guzmán, Inés, León-Asuero, José Manuel, and Casals-Martín, Fernando
- Abstract
The workplace is a key setting for the prevention of occupational risks and for promoting healthy activities such as physical activity. Developing a physically active lifestyle results in many health benefits, improving both well-being and quality of life. This article details the experience of two Spanish companies that implemented a program to promote physical exercise in the workplace, called “A Million Steps.” This program aimed to increase the physical activity of participants, challenging them to reach at least a million steps in a month through group walks. Participant workers reached the set goal and highlighted the motivational and interpersonal functions of the program.
- Published
- 2017
- Full Text
- View/download PDF
46. Análisis del efecto san Mateo en un estudio longitudinal sobre el desarrollo lector durante la educación primaria (1.° a 5.°)
- Author
-
Aguilar Villagrán, Manuel, Aragón Mendizabal, Estíbaliz, Navarro Guzmán, José I., Delgado Casas, Cándida, and Marchena Consejero, Esperanza
- Abstract
El efecto san Mateo en lectura se refiere al fenómeno contrastado de cómo las diferencias en el rendimiento entre buenos y malos lectores pueden incrementarse a lo largo del tiempo de escolarización. Presentamos un estudio longitudinal acerca de la presencia/ausencia del efecto san Mateo en una muestra de estudiantes evaluados desde 1.° a 5.° de educación primaria. Cincuenta y un estudiantes que comenzaron en 2011 la educación primaria fueron evaluados en pruebas de lectura (TECLE, PROLEC-R, ACL y BEL) en 5 ocasiones (cada mes de junio entre los años 2011 y 2015). Se seleccionó a un grupo de niños (n=13) considerado en riesgo (usando el criterio del centil por debajo de 25 en la prueba TECLE aplicada al finalizar 1.° de educación primaria) y comparamos, durante 5 cursos evaluados, el desarrollo de la lectura de este grupo de riesgo con un grupo de lectores medios (n=26) y de lectores de nivel alto (n=12) en la misma muestra de participantes. Los resultados, al realizar un seguimiento del perfil lector del alumnado en riesgo, permiten valorar los cambios y mejoras producidos en este alumnado entre las distintas evaluaciones a lo largo de los años de duración del estudio. Los resultados globales muestran diferencias entre los grupos evaluados pero no un aumento de estas entre los lectores en riesgo y los demás grupos. Asimismo, el seguimiento individual del alumnado en riesgo constata que alguno de ellos mejora en los parámetros de lectura por encima de la media general. Se discuten algunas implicaciones educativas del estudio.
- Published
- 2017
- Full Text
- View/download PDF
47. Benefits of Emergency Departments’ Contribution to Stroke Prophylaxis in Atrial Fibrillation
- Author
-
Coll-Vinent, Blanca, Martín, Alfonso, Sánchez, Juan, Tamargo, Juan, Suero, Coral, Malagón, Francisco, Varona, Mercedes, Cancio, Manuel, Sánchez, Susana, Carbajosa, José, Ríos, José, Casanovas, Georgina, Ràfols, Carles, del Arco, Carmen, Agud, María, Aguilar, José, Aguirre, Alfons, de Simón Almela, Amparo, Almirall, Mercè, Álvarez, Oscar, Amador, Luis, Andueza, Juan Antonio, Aramburu, Francisco José, Ayala, Ignacio, Bajo, Ángel, Bilbaíno, Carlos, Calvo, Ricardo, Díaz, María Elena, Estévez, Maria Jesús, Flaño, Cristina, Fuenzalida, Carolina, Garcés, Cristina, García, María Teresa, García, Pedro, García-Castrillo, Luis, Gargallo, Carmen, Garrido, José Manuel, González, Juan, Herrero, Pablo, Jiménez, Eduardo, Jiménez, Gregorio, Lázaro, José, Lopetegui, Pedro, López, Ignacio, Lubillo, José Maria, Marchena, María José, Moya, Francisco, Mozota, Julián, Navarro, Francisco José, Palom, Xavier, Ochoa, Javier, Peiró, Ana María, Parra, Juan Manuel, Perea, Álvaro, Piñera, Pascual, Riambau, Pere, Richard, Fernando, Rodríguez, Belén, Rodríguez, Roberto, Ruiz, Eva, Ruiz, Francisco, Segarra, Ana Maria, Seijas, Carmen, Sesma, Javier, Soler, Wilfredo, Sousa, María del Mar, Torres, José Manuel, Trejo, Olga Maria, and Vicente, José
- Abstract
Supplemental Digital Content is available in the text.
- Published
- 2017
- Full Text
- View/download PDF
48. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE
- Author
-
Jara-Palomares, Luis, Otero, Remedios, Jimenez, David, Carrier, Marc, Tzoran, Inna, Brenner, Benjamin, Margeli, Mireia, Praena-Fernandez, Juan Manuel, Grandone, Elvira, Monreal, Manuel, Monreal, Manuel, Decousus, Hervè, Prandoni, Paolo, Brenner, Benjamin, Barba, Raquel, Di Micco, Pierpaolo, Bertoletti, Laurent, Tzoran, Inna, Reis, Abilio, Bosevski, Marijan, Bounameaux, Henri, Malý, Radovan, Wells, Philip, Papadakis, Manolis, Aibar, M.A., Alfonso, M., Asensio-Cruz, M.I., Auguet, T., Arcelus, J.I., Barba, R., Barrón, M., Barrón-Andrés, B., Bascuñana, J., Blanco-Molina, A., Bueso, T., Cañas, I., Ceausu, A., Chic, N., Culla, A., del Pozo, R., del Toro, J., Díaz-Pedroche, M.C., Díaz-Peromingo, J.A., Duffort, M., Elias-Hernández, T., Falgá, C., Fernández-Aracil, C., Fernández-Capitán, C., Fidalgo, M.A., Font, C., Font, L., Gallego, P., García, M.A., García-Bragado, F., García-Rodenas, M., Gómez, V., González, J., Grau, E., Grimón, A., Guijarro, R., Guirado, L., Gutiérrez, J., Hernández-Comes, G., Hernández-Blasco, L., Hernando-López, E., Jara-Palomares, L., Jaras, M.J., Jiménez, D., Joya, M.D., Llamas, P., Lecumberri, R., Lobo, J.L., López-Jiménez, L., López-Reyes, R., López-Sáez, J.B., Lorente, M.A., Lorenzo, A., Maestre, A., Marchena, P.J., Martín, M., Martín-Martos, F., Monreal, M., Nieto, J.A., Nieto, S., Núñez, A., Núñez, M.J., Odriozola, M., Otalora, S., Otero, R., Ovejero, A., Pedrajas, J.M., Pérez, G., Pérez-Ductor, C., Peris, M.L., Porras, J.A., Reig, O., Riera-Mestre, A., Riesco, D., Rivas, A., Rodríguez-Dávila, M.A., Rosa, V., Ruiz-Artacho, P., Ruiz-Giménez, N., Sahuquillo, J.C., Sala-Sainz, M.C., Sampériz, A., Sánchez, R., Sanz, O., Soler, S., Sopeña, B., Suriñach, J.M., Tolosa, C., Trujillo-Santos, J., Uresandi, F., Valero, B., Valle, R., Vela, J., Vicente, P., Vidal, G., Villalobos, A., Villalta, J., Vanassche, T., Verhamme, P., Wells, P., Hirmerova, J., Malý, R., Salgado, E., Bertoletti, L., Bura-Riviere, A., Farge-Bancel, D., Hij, A., Mahé, I., Merah, A., Moustafa, F., Papadakis, M., Braester, A., Brenner, B., Tzoran, I., Antonucci, G., Barillari, G., Bertone, A., Bilora, F., Bortoluzzi, C., Ciammaichella, M., Di Girolamo, C., Di Micco, P., Duce, R., Ferrazzi, P., Giorgi-Pierfranceschi, M., Grandone, E., Lodigiani, C., Maida, R., Mastroiacovo, D., Pace, F., Pesavento, R., Pinelli, M., Poggio, R., Prandoni, P., Rota, L., Tiraferri, E., Tonello, D., Tufano, A., Visonà, A., Zalunardo, B., Drucka, E., Kigitovica, D., Skride, A., Sousa, M.S., Bosevski, M., Zdraveska, M., Bounameaux, H., and Mazzolai, L.
- Abstract
The benefits of a diagnostic workup for occult cancer in patients with VTE are controversial. Our aim was to provide and validate a risk score for occult cancer in patients with VTE.
- Published
- 2017
- Full Text
- View/download PDF
49. El monorriel como sistema de transporte masivo para la ciudad de Santo Doming
- Author
-
Ramírez De Marchena, Alex
- Published
- 2017
50. Adenocarcinoma gástrico: ¿debemos asociar pancreaticoduodenectomía ante sospecha intraoperatoria de infiltración?
- Author
-
Acosta-Mérida, M.A., Ortiz-López, D., Callejón-Cara, M.M., Rahy-Martín, A., and Marchena-Gómez, J.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.